Extended release exenatide was superior in lowering PPG, had a low incidence of hypoglycemia but a greater incidence of gastrointestinal adverse events
Whitney Evans, PhD, RD, Director of Scientific Affairs at Danone, said: GLP-1 medications can lead to substantial weight loss, but they can also create unique nutrition challenges as they can substantially reduce food and calorie intake but do not change essential nutrient needs
Results GLP-1RAs alleviate RA progression by suppressing synovial inflammation and cartilage destruction Recent studies have demonstrated that GLP-1RAs not only exert significant metabolic effects in the management of diabetes and obesity, but also possess anti-inflammatory properties [33]
Complete prevention isn't guaranteed, but proactive measuressmaller meals, no eating before bed, trigger-food avoidancecan significantly reduce or eliminate symptoms
The post says probiotic formulations are broadly considered safe for most people, but that safety turns on individual microbiome composition, baseline gut health, and concurrent medications rather than the ingredients alone
